You are here

Eu Yan Sang offeror faces stumbling block in compulsory acquisition


ALTHOUGH the public float in Eu Yan Sang International (EYSI) has fallen below the required 10 per cent for it to stay listed, the consortium making the bid to take the traditional Chinese medicine (TCM) group private is still not entitled to proceed with compulsory acquisition...

Market voices on: